🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06644352
Recruiting Not applicable

Right Versus Left Thoracic Surgical Approaches for Siewert II Gastroesophageal Junction Adenocarcinoma

NCT06644352 · tracked via the Priya Life Science China tracker
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase
Not applicable
Started
2022-07-01
Last updated
2024-10-16

Condition(s) studied

Siewert Type II Adenocarcinoma of Esophagogastric Junction

Investigational drug(s) / intervention(s)

different thoracic surgical approaches

different thoracic surgical approaches: Right Versus Left Thoracic Surgical Approaches

Study summary

To explore the 5-year overall survival (OS) of right versus left thoracic surgical approaches for patients with locally advanced Siewert II gastroesophageal junction adenocarcinoma treated by neoadjuvant chemotherapy

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: 1. Histologically confirmed gastroesophageal adenocarcinoma; 2. R0 resectable Siewert Ⅱ, cT2-3N0-3M0 (AJCC V8 TNM classification); 3. Have a performance status of 0 or 1 on the ECOG Performance Scale; 4. Age 18-80 years old, both men and women; 5. Estimated survival ≥6 months; 6. Be willing and able to provide written informed consent/assent for the trial; 7. Demonstrate adequate organ function ; 8. Female subject of childbearing potential should have a negative urine or serum pregnancy within 7 days before enrollment. If the urine test is positive or cannot be confirmed as negative, a serum pregnancy test will be required; 9. Have not received systemic or local treatment for esophageal cancer in the past. Exclusion Criteria: 1. Have a history of other malignant tumors in the past or at the same time; 2. Previous upper abdominal surgery (excluding cholecystectomy); 3. Bleeding, perforation and obstruction requiring emergency surgical treatment; 4. Severe heart, lung, liver and kidney dysfunction, which the researcher thinks is not suitable for operation; 5. Hydrothorax and ascites with clinical symptoms need therapeutic puncture or drainage; 6. Participate in other clinical studies or less than 1 month from the end of the previous clinical study; 7. Have a history of psychoactive drug abuse, alcoholism or drug abuse; 8. Be unable or do not agree to bear the inspection and treatment expenses at their own expense; 9. The researcher thinks that it should be excluded from this study.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Cancer Hospital Chinese Academy of Medical Sciences Beijing China Recruiting

More Cancer Institute and Hospital, Chinese Academy of Medical Sciences trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06644352 on ClinicalTrials.gov ↗ ← All trials in China